Prevalence Of Cardiac Autonomic Neuropathy In Patients With Diabetes
Cardiac Autonomic Neuropathy In Patients With Diabetes
Keywords:
Diabetic autonomic neuropathy, diabetes mellitus complication, type 2 diabetes mellitusAbstract
Background: Autonomic neuropathy is a serious complication of diabetes mellitus. Cardiac autonomic neuropathy (CAN) is chronic diabetic complication with variable prevalence and clinical manifestations. Prevalence of CAN remains less explored domain among type 2 diabetic population. Aim: To analyse the prevalence of CAN in type 1 and type 2 DM. Materials and methods: A total of 152 cases with DM were selected for the study following strict inclusion and exclusion criteria. All the cases underwent a battery of cardiovascular reflex tests designed by Ewing. Results: We observed that overall prevalence of CAN was 51.9%. Prevalence of sympathetic and parasympathetic CAN was 28.9% and 44% respectively. When compared, prevalence of CAN in type 1 patients was significantly different from type 2. Further, significant difference was noted between parasympathetic and sympathetic CAN in these patients. Conclusion: Study concludes that, prevalence of CAN in type 1 DM is higher than type 2. Parasympathetic CAN prevalence is higher than sympathetic CAN in both groups.
References
2. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 1994; 10:339-383.
3. Vinik AI. Diagnosis and management of diabetic neuropathy. Clin Geriatr Med 1999; 15:293–320.
4. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26 (5):1553–79.
5. Diabetologia. 2011 Dec; 54(12):3022-7. Epub 2011 Sep 30.
6. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982 Oct; 285:916-18.
7. Zola B. Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinal Metab 1986; 63:208-14.
8. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001; 68:928–944.
9. Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract 2002; 58:131–38.
10. Ewing DJ. Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med 1978; 55:321–27.
11. Clarke BF, Ewing DJ, Campbell IW. Diabetic autonomic neuropathy. Diabetologia 1979; 17:195–212.
12. Ewing DJ, Campbell IW, Clark BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 1980; 92:308–11.
13. Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, and Sujathan P et al. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis Postgrad Med J 2008; 84:205-210.
14. O’Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 1991; 79:495–502.
15. Ziegler D, Gries FA, Spuler M, Lessmann F, Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group: The epidemiology of diabetic neuropathy. J Diabetes Complications 1992; 6:49–57.
16. Granberg V, Ejskjaer N, Peakman M, Sundkvist G. Autoantibodies to Autonomic Nerves Associated With Cardiac and Peripheral Autonomic Neuropathy. Diabetes Care 2005; 28(8):1959–64.
17. American Diabetes Association, American Academy of Neurology: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes Care 1988; 11:592–97.
18. Freccero C, Wollmer P, Svensson H, Sundkvist G, Bornmyr S. Sympathetic and parasympathetic neuropathy are frequent in both type 1and type 2 diabetic patients. Diabetes Care 2004; 27(12):2936–41.
19. Khandelwal E, Jariyal AK, Deepak KK. Pattern and prevalence of cardiovascular autonomic neuropathy in diabetics visiting a tertiary care referral center in India. Indian J Physiol Pharmacol 2011; 55 (2):119–27.
